Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. - Wikidata - wikimedia - TriplyDB

Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

http://www.wikidata.org/entity/Q34143196

about

Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritis HIV: inflammation and bone Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.Bones and Crohn's: problems and solutions.Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells.Physiology of bone loss.Female reproductive system and bone.Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor Influence of interleukin-1 receptor antagonist gene polymorphism on disease.Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency Osteoporosis in the rheumatic disease patient.Monitoring hormone replacement therapy by biochemical markers of bone metabolism in menopausal women M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.Microarray analysis of human adipose-derived stem cells in three-dimensional collagen culture: osteogenesis inhibits bone morphogenic protein and Wnt signaling pathways, and cyclic tensile strain causes upregulation of proinflammatory cytokine regul The anti-inflammatory role of vitamin e in prevention of osteoporosis.Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae.Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice Interactions between the immune system and bone.Estrogen and the skeleton Acute versus chronic phase mechanisms in a rat model of CRPS.Bone remodeling in post-menopausal osteoporosis.Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency.Usefulness of ceruloplasmin testing as a screening methodology for geriatric patients with osteoporosis.Postmenopausal osteoporosis: the role of immune system cells Bone effects of biologic drugs in rheumatoid arthritis.Regulation of bone turnover by sex steroids in men Osteopenia and decreased bone formation in osteonectin-deficient mice.Effects of ginsenosides rg1 on osteoblasts cultured with ti particles.Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis.The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome.Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency.Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis.Alcohol, cytokines, and estrogen in the control of bone remodeling.Inflammatory bone loss in experimental periodontitis induced by Aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice.Periprosthetic osteolysis: characterizing the innate immune response to titanium wear-particles.Reduction of inflammation and pyrexia in the rat by oral administration of SDZ 224-015, an inhibitor of the interleukin-1 beta converting enzyme.

P2860

Q24805600-D47C2ADC-05B3-446E-B59F-402F5A37FB9F Q27010898-75A825C6-BBB7-44FA-9C7B-AB9FE07B4B14 Q28586541-B1A79882-8B2C-4E8D-A391-9B0549083D96 Q30560117-036B7FF9-D738-4C9B-AD72-094F6B55BF76 Q33715520-68A68058-D4CB-4ACB-86D3-DF9DFFAC6DE0 Q33854310-1C2AF673-F6CA-4748-B7B4-064EA8850A34 Q33980978-2A932204-0C51-4F63-9634-D136274E4092 Q34142868-E079E91E-045C-4A2D-8DC8-4131131A7B49 Q34224435-6C106905-128E-4E71-9B2E-E3847C118FE2 Q34461355-9D10BE04-5297-4D8B-8BAD-73E09D0EF2A7 Q34816640-1746992F-1130-4F3A-B17F-0511B3FB4113 Q34986976-E6FD21F3-1638-4BBF-BE98-58ABFA291019 Q35037634-ACE8DFD9-6D20-40AF-AB80-2C5B1983A28A Q35159009-FE2C0861-FAC5-4BF0-8AE3-F88B725101EE Q35169193-0E422DD2-C570-4DE9-84AF-BBC8B6B07758 Q35476764-8A793606-7EA6-464B-90D9-32FE30603C4F Q35580008-CA67EE7D-8E38-4F0D-8728-E553DE3C9273 Q35751206-31F63F3C-8B32-4B6D-B12A-0B4A9385B58F Q35824596-8CB2BCF8-43F1-43E7-8AEE-E56C5446F770 Q35825391-13CBF864-CF36-4446-99AB-210813B371B5 Q36179747-AE8B26A1-8461-4342-822D-129D546CF89D Q36480963-A07AF274-C055-4ABE-A1BA-69DC25954575 Q36518536-27F3F066-C275-4830-9A32-302A4029E20C Q36566505-2DF3356E-5158-4A19-BBAB-ACBBA92359FF Q36586758-9B611BC4-9281-452F-B6B8-873D2D3FF3FF Q36914237-3A0A4142-709D-4BF6-BEDF-7F96A664E2B0 Q36995387-9FB425C7-0BDC-4B47-8A23-5CD3B0EFA05D Q37172776-46D58001-2751-4610-96BD-02B377377565 Q37176145-08ED3D4A-511E-4331-9F6C-64A3F9A48648 Q37219405-775785B2-F8C4-414E-B43D-E49AF4215B84 Q37271202-93EA0D59-CF91-470E-A3D1-4BC4024A95E0 Q37287589-54245949-5654-44DD-8D78-373365235E94 Q37345168-9517D341-309C-46FB-B1E8-4A4AF3B893A2 Q37365710-72E33D66-11CA-4E3E-960F-17E03023C472 Q37388035-85862487-DD0E-40A8-8352-999D2946E7F9 Q37801555-E3006A29-1314-4D7D-A409-9D556481A49E Q38557872-92DC962A-3DFA-46F6-BEA3-948D5CD95B00 Q38852509-A1FC9230-A2D9-4C3C-8730-9192AC021926 Q39287355-2F0C4B92-543F-4F38-8C92-9EFA6778831D Q40684474-4AC7C338-0165-4408-9547-09ED0875A5AA

P2860

Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.

http://www.wikidata.org/entity/Q34143196

description

1994 nî lūn-bûn

@nan

1994 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Interleukin-1 receptor antagon ...... rption in ovariectomized rats.

@ast

Interleukin-1 receptor antagon ...... rption in ovariectomized rats.

@en

Interleukin-1 receptor antagon ...... rption in ovariectomized rats.

@nl

type

label

Interleukin-1 receptor antagon ...... rption in ovariectomized rats.

@ast

Interleukin-1 receptor antagon ...... rption in ovariectomized rats.

@en

Interleukin-1 receptor antagon ...... rption in ovariectomized rats.

@nl

prefLabel

Interleukin-1 receptor antagon ...... rption in ovariectomized rats.

@ast

Interleukin-1 receptor antagon ...... rption in ovariectomized rats.

@en

Interleukin-1 receptor antagon ...... rption in ovariectomized rats.

@nl

P1433

Q34143196-8F5B620F-764D-47B9-8A18-2C4EEFD1A50B

P1476

Q34143196-95903581-8C05-4AEB-B410-004A29654DE8

P2093

Q34143196-5B1F4FD9-EFE9-4DB1-B4B8-8A1AB8F9C271

Q34143196-900B697E-1613-491B-9CA3-E344045E6689

Q34143196-A9191B2C-A9FF-4791-85A4-2D3545ED4666

Q34143196-B2BC4544-5173-4186-B0CE-3E8787DC1C1B

Q34143196-C109C22F-007D-4160-AD73-3BA89CCD89C4

Q34143196-CE4FFD7D-8A57-44D1-B739-115AE49797AA

Q34143196-CF0D1ED9-B8BE-46A5-B762-3EAF7D4CCDC3

Q34143196-D39A8A73-E241-46C2-862A-95C3F0265E79

P2860

Q34143196-0296376B-D696-4ECF-8CD5-D9D41AB9916A

Q34143196-05BF08E0-124E-4FEF-9E44-0A9EBD1D69B9

Q34143196-0B979DE5-8DF2-49CA-B713-90B04B5A40DF

Q34143196-0DE06C1F-3E4C-452C-8421-B38143CA4D63

Q34143196-0F7E17EB-0CA9-4672-8FA2-49EB8EDB22D1

Q34143196-1C379E45-1009-46FA-91D6-5B158845F196

Q34143196-1C6076DD-3706-4E6E-AEB8-B2C9F3814DB5

Q34143196-1ECB17E8-2D39-4F04-B811-E79406B4608E

Q34143196-2E4E98E6-7DB7-4427-8490-529DD62C667C

Q34143196-414D2039-A432-454C-BCFB-5CCF8FA5CB57

P304

Q34143196-DBE591E7-16AA-40B2-AA5D-A7F14D5913D8

P31

Q34143196-F47617A2-58FA-4855-9094-797DF6404F76

P356

Q34143196-D5589B74-822D-403E-B823-DFAE9DE2027F

P407

Q34143196-825EE97D-CCB8-4500-A9E1-047B9D684C87

P433

Q34143196-C1884944-4B55-4FB1-8F6E-A1706D165260

P478

Q34143196-7F6E7728-E4E5-4341-85E6-FBFEA0EAD325

P577

Q34143196-44543505-C043-4077-A413-28CE3193ABDF

P698

Q34143196-70075714-9166-4DD8-8EB1-5B80B5088963

P921

Q34143196-62cc5e05-2319-4652-bc3e-7e40786433e0

P932

Q34143196-0833AB9A-C77C-4B84-84C5-3A57FD0F9F45

P356

P1433

Journal of Clinical Investigation

P1476

Interleukin-1 receptor antagon ...... rption in ovariectomized rats.

@en

P2093

C Brownfield

http://www.w3.org/2001/XMLSchema#string

D C Bloedow

http://www.w3.org/2001/XMLSchema#string

J L Vannice

http://www.w3.org/2001/XMLSchema#string

R B Kimble

http://www.w3.org/2001/XMLSchema#string

R C Thompson

http://www.w3.org/2001/XMLSchema#string

R Pacifici

http://www.w3.org/2001/XMLSchema#string

V T Kung

http://www.w3.org/2001/XMLSchema#string

W Hopfer

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice.

Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.

Involutional osteoporosis.

Effect of ovariectomy and prednisolone on bone mineral content in rats: evaluation by single photon absorptiometry and radiogrammetry.

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.

Sex steroids and bone mass. A study of changes about the time of menopause

17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.

P304

1959-1967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI117187

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

1994-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8182127

http://www.w3.org/2001/XMLSchema#string

P921

P932

294303

http://www.w3.org/2001/XMLSchema#string